Please assess the completion status of the following clinical trial:

Trial Title: Oral Penicillin Challenge and Allergy De-labeling in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients in the pediatric emergency department who are 2-17 yo and labeled as penicillin-allergic (including amoxicillin or other penicillin allergies)~2. Patients at low risk of anaphylaxis as determined by the study questionnaire~3. Patients who would normally be prescribed amoxicillin, amoxicillin-clavulanate or another penicillin for their current bacterial infection, including otitis media, Group A Streptococcal pharyngitis, pneumonia. sinusitis, dog and cat bite wounds, regimens for Helicobacter pylori eradication, or other acute infections deemed susceptible.~4. Patients who are interested in participating~5. Patients who have an acceptable surrogate to give consent on the subject's behalf~6. Patients whose surrogate (parent/caregiver) speaks English or Spanish~Exclusion Criteria:~1. Patients who are uninterested in participating, or their parents/caregivers are not interested in having them participate~2. Patients who have multiple drug allergies

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Oral Challenge (Type: EXPERIMENTAL): Patients will be screened for high vs. low risk of penicillin allergy. Low risk patients will be randomized to oral amoxicillin 500 mg challenge.
- No Oral Challenge (Type: NO_INTERVENTION): Patients will be screened for high vs. low risk of penicillin allergy. Low risk patients will be randomized to no oral amoxicillin 500 mg challenge..

Based on this trial design, predict the completion outcome and termination type (if applicable).